Equine Diagnostic Services - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The equine diagnostic services market size was valued at USD 296.5 million in 2025 and is estimated to grow from USD 314.20 million in 2026 to reach USD 422.80 million by 2031, at a CAGR of 6.09% during the forecast period (2026-2031). This report is Segmented by Service Type (Laboratory Diagnostics, Imaging Services, and More), End-User / Provider Setting (Commercial Veterinary Reference Laboratories, Equine Referral & Specialty Hospitals, and More), and Geography (North America, Europe, Asia-Pacific, and More). The Market and Forecasted in Terms of Value (USD).

Global Equine Diagnostic Services Market Trends and Insights

Advanced Imaging Access (standing MRI/CT) Accelerating Definitive Lameness Diagnosis

Standing MRI and weight-bearing CT have compressed workups from anesthesia-based day procedures to short sedated sessions, which cuts risk and enables same-day treatment planning in performance horses. Hallmarq reports that standing MRI improves visualization of early bone and soft-tissue changes relevant to high-value athletes that traditional radiography can miss when changes are subtle, which supports earlier offloading protocols and better outcomes. Weight-bearing CT from vendors such as Asto CT adds 3D assessment under physiological load that can reveal pathology not seen with recumbent imaging, which is critical for distal-limb evaluation in racing and jumping cohorts. Large-bore systems have extended standing coverage into proximal regions and cervicothoracic junctions in major centers, which widens case eligibility for sedation-only protocols. Practices are pairing modalities to correlate findings within a single visit, and teleoperated scanning is helping sites without on-staff specialists to run advanced cases efficiently. These shifts are raising the diagnostic baseline across referral hubs and lifting throughput in the equine diagnostic services market.

Rapid Adoption of Molecular PCR/qPCR for Outbreak Management

High-profile EHV-1 events have pushed PCR from confirmatory testing to frontline screening at event arrival and during quarantine, which hardwires molecular workflows into routine movement and competition. Reference centers such as Cornell AHDC and Colorado State ramped surge capacity during outbreaks, while panels for fever-of-unknown-origin broadened to close blind spots in septic and enteric causes of pyrexia. Evidence-based sampling is central to strangles control since guttural pouch lavage is far more sensitive than nasopharyngeal swabs and qPCR outperforms culture, which reduces the risk of silent carriers seeding new cases. Time-to-result is becoming a key differentiator as stall-side LAMP units and next-generation multiplex PCR panels compress decisions from days to hours, which improves quarantine precision and reduces facility downtime. New integrated respiratory kits, such as bioMérieux VETFIRE, place multi-pathogen PCR into a single self-contained cartridge, which removes cold-chain hurdles and supports adoption in regions with limited courier networks. This operational evolution shifts steady volumes into the equine diagnostic services market and raises the baseline for outbreak readiness at shows and sales.

High Procedure and Per-Test Costs with Uneven Insurance Coverage

Advanced imaging prices and multi-modality cascades can exceed annual coverage limits for many owners, which suppresses elective utilization for non-elite horses. Even basic imaging packages include sedation, interpretation, and facility fees that raise the final bill beyond the headline scan price, which makes transparent estimates and tiered offerings an important trust driver. Stall-side diagnostics reduce courier expenses and time lost to shipping, but they add cartridge and consumable costs that practices must price into emergency and after-hours services. Insurance structures often impose deductibles and co-pays that compound when cases require follow-up scans or interventional procedures, which can cause owners to pause between modalities even when clinical urgency remains. Clinics are responding with menu-based options that align scan scope to a single region and same-day discharge, which helps price-sensitive clients move forward without committing to full hospitalization or multi-region imaging. Until insurance coverage rises or bundled care models spread, cost friction will temper volume growth in certain owner segments within the equine diagnostic services market.

Other drivers and restraints analyzed in the detailed report include:

• Expansion of Stall-Side/Ambulatory Diagnostics in Equine Practice
• Growth in Organized Equestrian Sport and Stricter Biosecurity/Anti-Doping Programs
• Scarcity of Board-Certified Equine Imaging Specialists/Radiologists

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Laboratory Diagnostics held 36.98% of the 2025 share of the equine diagnostic services market size, reflecting entrenched use of reference centers for hematology, immunoassays, and complex culture workflows that still outperform many field kits for breadth and sensitivity. Point-of-care or field diagnostics is projected to expand at an 8.93% CAGR through 2031 as cartridge platforms, portable blood gas analyzers, and mobile ultrasound improve case throughput at the stable, which reduces dependency on overnight couriers and aligns decisions to the clinical clock. Imaging Services, including radiography, ultrasound, MRI, CT, and endoscopy, concentrate revenue because advanced modalities command higher per-case fees despite lower unit volumes than basic scans, and standing MRI and weight-bearing CT are now core offerings in many referral networks. Genetic testing remains a niche but is gaining relevance in high-value breeding decisions as reproductive programs formalize pre-implantation risk checks via targeted panels run through university or commercial labs. Endoscopy and specialty procedures such as guttural pouch lavage are critical for strangles carrier identification, and sampling guidance from academic labs is improving sensitivity and lowering reinfection risk, which reduces false reassurance from negative swab-only protocols.

In this context, on-instrument AI and software integration are pulling routine review tasks closer to the patient, which compresses lab-to-vet communication loops and helps ambulatory clinicians justify more complete workups in a single visit. FEI rule changes and competition medicine are raising same-day documentation needs for medications and welfare checks, which boosts demand for in-venue chemistry and hematology panels to document medical necessity and support eligibility under federated rules. Regional adoption paths diverge since mature markets build around advanced imaging hubs while fast-growing regions emphasize portable platforms that improve access without major facilities investment. As these patterns reinforce, a larger share of first-opinion cases complete the workup within the same day, which expands recurring demand in the equine diagnostic services industry while shifting mix from send-outs to stall-side decisions.

Complete Report Scope:

• By Service Type
  • Laboratory Diagnostics
  • Imaging Services
  • Point-of-Care / Field Diagnostics
  • Genetic Testing
  • Endoscopy & Other Procedures
• By End-user / Provider Setting
  • Commercial Veterinary Reference Laboratories
  • Equine Referral & Specialty Hospitals
  • Ambulatory / Field Veterinary Practices
  • Others
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Rest of Asia Pacific
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of MEA
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America held 41.66% of the 2025 share, sustained by state and federal requirements for disease surveillance and import biosecurity that institutionalize diagnostic use across movements and competitions. Interstate movement commonly hinges on recent Coggins tests and veterinary certificates, and imported breeding stock must clear multi-step quarantine screens such as serial cultures for contagious equine metritis, which embeds diagnostic demand in routine workflows. Event organizers and regulators maintain temperature logs and trigger PCR when thresholds are exceeded, which spreads molecular testing throughout show circuits and training centers. During EHV-1 events, university and state labs coordinate surge capacity and communications, which normalizes response times and reduces spread risk in large barns and event venues. Advanced imaging access is concentrated in and around university hubs and high-density equestrian regions, and teleoperations are extending coverage into adjoining states by decoupling scans from on-site specialist availability. These factors support steady growth in the equine diagnostic services market across the United States and Canada.

Europe pairs leading academic centers and racing hubs with mixed insurance environments, which produces strong adoption in referral clusters and more cautious uptake among non-racing clients in select countries. The Royal Veterinary College installed a large-bore standing CT system that enables sedation-only scans in wider anatomical regions, which broadens case eligibility and improves throughput in the UK’s referral ecosystem. European manufacturers and labs continue to launch multi-pathogen respiratory PCR kits and other integrated offerings, which helps synchronize workflows across clinics and reduces training overhead for new users. Federation harmonization and WOAH capacity building on laboratory expertise for equine diseases support improved cross-border movement and standardized surveillance practices, which is important for pan-European competition calendars. As referral hospitals educate clients on the value of standing imaging and as labs align result formats, predictable case flows can develop across national boundaries, which sustains demand in the equine diagnostic services market in Europe.

Asia-Pacific is the velocity leader on a percentage basis, anchored by Japan’s racing-driven imaging growth and Australia’s referral concentration, while large markets build advanced capacity in metro hubs. Japan Racing Association data on training center MRI use and regulatory discussions around distal-limb imaging reinforce how formal racing systems lift baseline demand for advanced modalities. Australia benefits from the University of Melbourne’s concentration of high-field imaging and CT in a single equine center, which acts as a regional magnet for complex cases in neighboring states and countries. Educational resources on CT techniques and cross-sectional anatomy continue to spread through training platforms, which accelerates skill diffusion among clinicians and radiographers in growing markets. As hubs in Asia-Pacific add standing CT and MRI alongside robust PCR programs, they seed concentric catchments that raise regional volumes in the equine diagnostic services market.

List of Companies Covered in this Report:

• Antech Diagnostics
• Asto CT
• Cornell University (Animal Health Diagnostic Center)
• Equine Diagnostic Solutions, LLC
• Equinosis, LLC
• Esaote S.p.A.
• Hallmarq Veterinary Imaging Ltd
• IDEXX
• IMV Imaging Ltd
• Kansas State University
• Moore Equine Veterinary Centre Ltd
• Rainbow Equine Hospital Ltd
• Royal Veterinary College, University of London
• Texas A&M University
• University of California, Davis
• University of Connecticut (CVMDL)
• Virginia Equine Imaging, PLLC
• Virginia Polytechnic Institute and State University
• Zoetis

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support